Management of primary pulmonary hypertension

British Journal of Cardiology

Volumn 9, Issue 6, 2002, Pages 330-332+335

  Mikhail, Ghada W ^a   Simon, J ^a   Gibbs, R ^a   Yacoub, Magdi H ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac catherisation; Investigations; Primary pulmonary hypertension; Surgical treatment; Vasodilators

Indexed keywords

ADENOSINE; AMLODIPINE; ANTICOAGULANT AGENT; BERAPROST; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIURETIC AGENT; DRUG; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; NIFEDIPINE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SHORT ACTING DRUG; SILDENAFIL; UNCLASSIFIED DRUG; UNIPROST; VASODILATOR AGENT; WARFARIN; ZANIPRAST;

ARTICLE; AWARENESS; BLOOD ANALYSIS; BRONCHIOLITIS; CATHETER INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MEGADOSE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; ENDARTERECTOMY; FUNCTIONAL ASSESSMENT; GENERAL PRACTITIONER; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFUSION PUMP; INJECTION PAIN; INJECTION SITE; LONG TERM CARE; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; OXYGEN THERAPY; PATIENT REFERRAL; PROGNOSIS; PULMONARY HYPERTENSION; SCREENING TEST; SYMPTOM; THORAX RADIOGRAPHY; THROMBOSIS;

EID: 0036286859     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
2. Clinical correlates and prognostic significance of six minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing
3. Development of a shuttle walking test of disability in patients with chronic airways obstruction
4. A comparison of acute hemodynamic effects of prostacyclin and hydralazine in primary pulmonary hypertension
5. Recommendations on the management of pulmonary hypertension in clinical practice
6. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy
7. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
8. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial
9. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin
10. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group
11. Vasodilator therapy for primary pulmonary hypertension in children
12. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
13. Aerosolised prostacyclin in adult respiratory distress syndrome
14. An evaluation of nebulized prostacyclin in primary and secondary pulmonary hypertension
15. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: Comparison with enzymatically formed nitric oxide from L-arginine
16. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung and Blood Institute Primary Pulmonary Hypertension Registry
17. von Willebrand factor abnormalities in primary pulmonary hypertension
18. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension
19. Coagulation activation, fibrinolysis and severity of pulmonary hypertension
20. Primary pulmonary hypertension: Natural history and the importance of thrombosis
21. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension
22. Primary pulmonary hypertension: Diagnosis, medical and surgical treatment
23. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
24. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH study group
25. Long term effects of UT-15 on hemodynamics and exercise tolerance in primary pulmonary hypertension
26. The in vitro and ex vitro antiplatelet effect of TPK-100, a stable prostacyclin analog, in several species
27. General pharmacology of beraprost sodium, second communication: Effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects
28. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: A placebo-controlled study
29. Bosentan therapy for pulmonary arterial hypertension
30. Sildenafil in primary pulmonary hypertension
31. Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs
32. Selective pulmonary vasodilation induced by aerosolized zaprinast
33. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension
34. Mid-term results of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension
35. Pulmonary thromboendarterectomy
36. Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment
37. Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension
38. Regression of primary pulmonary hypertension